If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKosmos Energy Regulatory News (KOS)

Share Price Information for Kosmos Energy (KOS)

Share Price is delayed by 15 minutes
Get Live Data
161.50    0.00 (0.00%)
Bid:
153.00
Ask:
159.00
Spread: 6.00 (3.922%)
Market Cap: £958.00m
KOS Live PriceLast checked at - London Stock Exchange

Intraday Kosmos Energy Share Chart

Director/PDMR Shareholding

7 Feb 2025 07:00

RNS Number : 2357W
Kosmos Energy Limited
07 February 2025
 

Kosmos Energy Ltd (the "Company")PDMR Shareholding

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

06 February 2025

The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Stock in the Company:

PDMR

Date of transaction

No. of shares vested

No. of shares granted

No. of shares sold or withheld

Christopher J. Ball

4 February 2025

0

0

138,584

Christopher J. Ball

5 February 2025

0

0

84,898

Josh R. Marion

4 February 2025

0

0

10,379

Josh R. Marion

5 February 2025

0

0

10,354

Ronald W. Glass

4 February 2025

0

0

10,379

Ronald W. Glass

5 February 2025

0

0

10,354

Andrew G. Inglis

4 February 2025

0

0

139,002

Andrew G. Inglis

5 February 2025

0

0

138,689

Neal D. Shah

4 February 2025

0

0

78,191

Neal D. Shah

5 February 2025

0

0

78,015

 

The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.

This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.

 

Josh R. Marion

Corporate Secretary

CONTACT:

Investor Relations

Jamie Buckland +44 203 954 2831 jbuckland@kosmosenergy.comMedia Relations

Thomas Golembeski +1-214-445-9674 tgolembeski@kosmosenergy.com

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Christopher J. Ball

b)

Position / status

SVP and Chief Commercial Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

138,584 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Company's Long Term Incentive Plan (the "Plan").

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1149

Volume

138,584

Total

431,675.30

d)

Aggregated information 

Price

3.1149

Volume

138,584

Total

431,675.30

e)

Date of the transactions

4 February 2025

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

84,898 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1219

Volume

84,898

Total

265,043.07

d)

Aggregated information 

Price

3.1219

Volume

84,898

Total

265,043.07

e)

Date of the transactions

5 February 2025

f)

Place of the transaction

NYSE

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Josh R. Marion

b)

Position / status

SVP and General Counsel

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

10,379 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1149

Volume

10,379

Total

32,329.55

d)

Aggregated information 

Price

3.1149

Volume

10,379

Total

32,329.55

e)

Date of the transactions

4 February 2025

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

10,354 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1219

Volume

10,354

Total

32,324.15

d)

Aggregated information 

Price

3.1219

Volume

10,354

Total

32,324.15

e)

Date of the transactions

5 February 2025

f)

Place of the transaction

NYSE

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Ronald W. Glass

b)

Position / status

Vice President and Chief Accounting Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

10,379 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1149

Volume

10,379

Total

32,329.55

d)

Aggregated information 

Price

3.1149

Volume

10,379

Total

32,329.55

e)

Date of the transactions

4 February 2025

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

10,354 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1219

Volume

10,354

Total

32,324.15

d)

Aggregated information 

Price

3.1219

Volume

10,354

Total

32,324.15

e)

Date of the transactions

5 February 2025

f)

Place of the transaction

NYSE

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Andrew G. Inglis

b)

Position / status

Chairman and Chief Executive Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

139,002 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1149

Volume

139,002

Total

432,977.33

d)

Aggregated information 

Price

3.1149

Volume

139,002

Total

432,977.33

e)

Date of the transactions

4 February 2025

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

138,689 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1219

Volume

138,689

Total

432,973.19

d)

Aggregated information 

Price

3.1219

Volume

138,689

Total

432,973.19

e)

Date of the transactions

5 February 2025

f)

Place of the transaction

NYSE

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Neal D. Shah

b)

Position / status

Senior Vice President and Chief Financial Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

78,191 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1149

Volume

78,191

Total

243,557.15

d)

Aggregated information 

Price

3.1149

Volume

78,191

Total

243,557.15

e)

Date of the transactions

4 February 2025

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

78,015 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1219

Volume

78,015

Total

243,555.03

d)

Aggregated information 

Price

3.1219

Volume

78,015

Total

243,555.03

e)

Date of the transactions

5 February 2025

f)

Place of the transaction

NYSE

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSLFIMEISEFE
Date   Source Headline
10th Dec 20207:00 amRNSCompletion of Exploration Farm Down to Shell
9th Dec 20204:35 pmRNSPrice Monitoring Extension
16th Nov 20204:41 pmRNSSecond Price Monitoring Extn
16th Nov 20204:36 pmRNSPrice Monitoring Extension
10th Nov 20204:38 pmRNSPrice Monitoring Extension
9th Nov 20207:00 amRNS3rd Quarter Results
14th Oct 20207:00 amRNSSuccessful Reserve Based Lending Re-determination
13th Oct 20207:00 amRNSKosmos Energy Announces Third Quarter Results Date
6th Oct 20204:35 pmRNSPrice Monitoring Extension
5th Oct 20207:00 amRNSClosing of $200 million Gulf of Mexico facility
9th Sep 20207:00 amRNSFarm Down of a Portfolio of Exploration Assets
3rd Sep 20207:00 amRNSConference Participation
26th Aug 20204:41 pmRNSSecond Price Monitoring Extn
26th Aug 20204:36 pmRNSPrice Monitoring Extension
25th Aug 20204:35 pmRNSPrice Monitoring Extension
19th Aug 20204:36 pmRNSPrice Monitoring Extension
12th Aug 20204:35 pmRNSPrice Monitoring Extension
7th Aug 20204:35 pmRNSPrice Monitoring Extension
4th Aug 20204:36 pmRNSPrice Monitoring Extension
3rd Aug 20207:00 amRNS2nd Quarter Results
7th Jul 20207:00 amRNSSecond Quarter Results Date
3rd Jul 20207:00 amRNSProduction Prepayment Agreement
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
29th Jun 20207:00 amRNSProduction Prepayment Agreement
23rd Jun 20204:35 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSResult of AGM
15th Jun 20204:40 pmRNSSecond Price Monitoring Extn
15th Jun 20204:35 pmRNSPrice Monitoring Extension
12th Jun 20204:36 pmRNSPrice Monitoring Extension
12th Jun 20207:00 amRNSDirector/PDMR Shareholding
5th Jun 20204:37 pmRNSPrice Monitoring Extension
27th May 20204:41 pmRNSSecond Price Monitoring Extn
27th May 20204:35 pmRNSPrice Monitoring Extension
21st May 20204:35 pmRNSPrice Monitoring Extension
20th May 20204:36 pmRNSPrice Monitoring Extension
14th May 20204:41 pmRNSSecond Price Monitoring Extn
14th May 20204:36 pmRNSPrice Monitoring Extension
13th May 20207:00 amRNSPublication of Proxy Statement
11th May 20203:00 pmRNSChief Financial Officer succession
11th May 20207:00 amRNS1st Quarter Results
6th May 20204:41 pmRNSSecond Price Monitoring Extn
6th May 20204:35 pmRNSPrice Monitoring Extension
24th Apr 20204:41 pmRNSSecond Price Monitoring Extn
24th Apr 20204:37 pmRNSPrice Monitoring Extension
23rd Apr 20204:42 pmRNSSecond Price Monitoring Extn
23rd Apr 20204:36 pmRNSPrice Monitoring Extension
23rd Apr 20207:00 amRNSFirst quarter results date
23rd Apr 20207:00 amRNSContinued Listing Standard Notice
20th Apr 20204:35 pmRNSPrice Monitoring Extension
15th Apr 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.